[3H]RX821002 (2-methoxyidazoxan) binds to α2-adrenoceptor subtypes and a non-adrenoceptor imidazoline binding site in rat kidney
- 5 December 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 316 (2-3) , 359-368
- https://doi.org/10.1016/s0014-2999(96)00692-9
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- α2D-Adrenoceptors modulate renal noradrenaline release in normotensive and spontaneously hypertensive ratsEuropean Journal of Pharmacology, 1994
- The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1‐ and I2‐sitesBritish Journal of Pharmacology, 1994
- Effects of imidazolines and derivatives on insulin secretion and vascular resistance in perfused rat pancreasEuropean Journal of Pharmacology, 1994
- Role of α2-Adrenoceptors and Imidazoline-Binding Sites in the Control of Insulin SecretionClinical Science, 1993
- Renal imidazoline preferring sites and solute excretion in the ratBritish Journal of Pharmacology, 1993
- Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non‐adrenoceptor idazoxan binding sitesBritish Journal of Pharmacology, 1993
- Subtypes of α 1 ‐ and α 2 ‐adrenergic receptorsThe FASEB Journal, 1992
- The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cellsEuropean Journal of Pharmacology, 1991
- Effect of imidazolines on Na+ transport and intracellular pH in renal proximal tubule cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- The imidazoline preferring receptor: binding studies in bovine, rat and human brainstemEuropean Journal of Pharmacology, 1989